Learn about spending and usage of medicines in the past year and outlook to the future, globally and across specific therapy areas and countries.
Discover trends in drug approvals and launches, pipeline activity, and data on clinical trial activity.
Examine the state of the U.S. health system, medicine usage, drug pricing, and costs for patients.
Explore research and development in oncology and the progress being made to improve representativeness of race and ethnicity in clinical trial populations.
Hear IQVIA Institute Executive Director Murray Aitken discuss R&D activity through the end of 2022, including drug approvals, medicines in the pipeline, clinical trial activity, clinical development productivity, innovation, funding, and more.
In this video, Murray Aitken offers a look at the past and future impact of COVID-19 on the use of medicines, the outlook for the use of medicines and key drivers of change, important therapy areas, and overall spending levels for all prescription drugs and key dynamics at a country, therapy, and product level – both historically and the outlook to 2027.
Achieving Sustainable Levels of Biosimilar Competition in Europe
Interactions between patient organizations and life sciences companies.